Asia · Regional markets · Vietnam Investment Review
Phase 1 Plodicitinib clinical data

Detailed summary
South Korean drugmaker Daewoong Pharmaceutical presented Phase 1 clinical trial data for its autoimmune disease candidate Plodicitinib during the ACR Convergence 2026 conference…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)



